Cargando…

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases

Obesity is now a worldwide epidemic ensuing an increase in comorbidities’ prevalence, such as insulin resistance, type 2 diabetes (T2D), metabolic dysfunction-associated fatty liver disease (MAFLD), nonalcoholic steatohepatitis (NASH), hypertension, cardiovascular disease (CVD), autoimmune diseases,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gutiérrez-Cuevas, Jorge, Santos, Arturo, Armendariz-Borunda, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583943/ https://www.ncbi.nlm.nih.gov/pubmed/34769060 http://dx.doi.org/10.3390/ijms222111629

Ejemplares similares

Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2021)

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2021)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
por: Sandoval-Rodriguez, Ana, et al.
Publicado: (2022)

The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications
por: Monraz-Méndez, C. Alejandra, et al.
Publicado: (2022)

TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism
por: Shepard, Christopher R.
Publicado: (2021)

From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications
por: Boccatonda, Andrea, et al.
Publicado: (2023)

Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
por: Galicia-Moreno, Marina, et al.
Publicado: (2020)

Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK
por: Sandoval‐Rodriguez, Ana, et al.
Publicado: (2020)

Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases
por: Griffett, Kristine, et al.
Publicado: (2023)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Pathophysiology of NASH in endocrine diseases
por: Gariani, Karim, et al.
Publicado: (2021)

MAFLD in Obese Children: A Challenging Definition
por: Di Sessa, Anna, et al.
Publicado: (2021)

Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
por: Kołakowski, Adrian, et al.
Publicado: (2022)

Mexican Ancestral Foods (Theobroma cacao, Opuntia ficus indica, Persea americana and Phaseolus vulgaris) Supplementation on Anthropometric, Lipid and Glycemic Control Variables in Obese Patients: A Systematic Review and Meta-Analysis
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2023)

Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study
por: Pal, Shreya C., et al.
Publicado: (2023)

Therapies Based on Nanoparticles for Eye Drug Delivery
por: Meza-Rios, Alejandra, et al.
Publicado: (2020)

Toward a New Generation of Bio-Scaffolds for Neural Tissue Engineering: Challenges and Perspectives
por: Villanueva-Flores, Francisca, et al.
Publicado: (2023)

Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability
por: Campos-Valdez, Marina, et al.
Publicado: (2021)

MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy
por: Xian, Ying-Xin, et al.
Publicado: (2021)

Delphinidin Ameliorates Hepatic Triglyceride Accumulation in Human HepG2 Cells, but Not in Diet-Induced Obese Mice
por: Parra-Vargas, Marcela, et al.
Publicado: (2018)

Molecular Basis and Current Treatment for Alcoholic Liver Disease
por: Miranda-Mendez, Alejandra, et al.
Publicado: (2010)

The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases
por: Tsutsumi, Tsubasa, et al.
Publicado: (2023)

Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China
por: Wang, Yuying, et al.
Publicado: (2022)

Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
por: Cordeiro, Adryana, et al.
Publicado: (2022)

Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
por: Filipovic, Branka, et al.
Publicado: (2023)

Molecular Pathogenesis of NASH
por: Caligiuri, Alessandra, et al.
Publicado: (2016)

Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models
por: Galicia-Moreno, Marina, et al.
Publicado: (2021)

Role of Insulin Resistance in MAFLD
por: Sakurai, Yoshitaka, et al.
Publicado: (2021)

The Gut Microbiome and Ferroptosis in MAFLD
por: Ji, Jie, et al.
Publicado: (2023)

MAFLD: a multisystem disease
por: Pipitone, Rosaria Maria, et al.
Publicado: (2023)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

MAFLD and Celiac Disease in Children
por: Scapaticci, Serena, et al.
Publicado: (2023)

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Unraveling the molecular links between benzopyrene exposure, NASH, and HCC: an integrated bioinformatics and experimental study
por: Yang, Zheming, et al.
Publicado: (2023)

Oxidative and Fibrinolytic Mechanisms: Two Important Processes to Consider in Platelet Storage
por: Garcia-Bañuelos, Jesus Javier, et al.
Publicado: (2023)

From MAFLD to hepatocellular carcinoma and everything in between
por: Bae, Sarah Da Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bnlp1mkhsmcs7peslah7ekcf3r